Does VEDOLIZUMAB Cause Folliculitis? 423 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 423 reports of Folliculitis have been filed in association with VEDOLIZUMAB (ENTYVIO). This represents 0.6% of all adverse event reports for VEDOLIZUMAB.
423
Reports of Folliculitis with VEDOLIZUMAB
0.6%
of all VEDOLIZUMAB reports
345
Deaths
297
Hospitalizations
How Dangerous Is Folliculitis From VEDOLIZUMAB?
Of the 423 reports, 345 (81.6%) resulted in death, 297 (70.2%) required hospitalization, and 267 (63.1%) were considered life-threatening.
Is Folliculitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VEDOLIZUMAB. However, 423 reports have been filed with the FAERS database.
What Other Side Effects Does VEDOLIZUMAB Cause?
Off label use (21,017)
Colitis ulcerative (13,455)
Crohn's disease (9,759)
Drug ineffective (8,424)
Diarrhoea (7,493)
Abdominal pain (6,401)
Fatigue (5,477)
Haematochezia (5,215)
Frequent bowel movements (4,527)
Arthralgia (4,028)
What Other Drugs Cause Folliculitis?
METHOTREXATE (4,146)
LEFLUNOMIDE (4,022)
ABATACEPT (3,977)
TOCILIZUMAB (3,951)
CERTOLIZUMAB PEGOL (3,781)
GOLIMUMAB (3,675)
ADALIMUMAB (3,572)
ACETAMINOPHEN (3,522)
RITUXIMAB (3,481)
CHLORHEXIDINE (3,405)
Which VEDOLIZUMAB Alternatives Have Lower Folliculitis Risk?
VEDOLIZUMAB vs VELAGLUCERASE ALFA
VEDOLIZUMAB vs VELCADE
VEDOLIZUMAB vs VELETRI
VEDOLIZUMAB vs VELIPARIB
VEDOLIZUMAB vs VEMURAFENIB